You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 1, July 1, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

How Many Pills Do Patients With HIV Infection Take?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.— Slowing of disease progression and reduction of opportunistic infections are vital to prolonged survival for patients with human immunodeficiency virus (HIV) infection and are conditional on patients taking all of their medication as prescribed. It has been suggested that the number of pills a patient is prescribed increases the complexity of their treatment and adversely affects adherence.1-2 Some drug manufacturers are suggesting twice-daily rather than thrice-daily dose schedules,3 whereas other researchers have described the benefits of 6-drug regimens.4 It is important for clinicians to be aware of the total number of pills current HIV regimens entail. To our knowledge, the number of pills patients with HIV infection are asked to take each day has not been quantified.

An anonymous self-report survey was completed by a convenience sample of 504 ambulatory patients at 9 clinics participating in the HIV Outpatient Study (HOPS).5 The survey asked the total number . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Pulse: THE MEDICAL STUDENT SECTION OFJAMA
JAMA. 1994;271(1):77-83.
PDF  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata
Palella et al.
ANN INTERN MED 2003;138:620-626.
ABSTRACT | FULL TEXT  

Mathematical biology and medical statistics: contributions to the understanding of AIDS epidemiology
Donnelly and Cox
Stat Methods Med Res 2001;10:141-154.
ABSTRACT  

Discontinuation of Chemoprophylaxis against Pneumocystis carinii Pneumonia in Patients with HIV Infection
Yangco et al.
ANN INTERN MED 2000;132:201-205.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.